Diabetes Mellitus, Hemoglobin A1C, and the Incidence of Total Joint Arthroplasty Infection

Journal of Arthroplasty

Volumn 27, Issue 5, 2012, Pages

  Iorio, Richard ^a   Williams, Kelly M ^a   Marcantonio, Andrew J ^a   Specht, Lawrence M ^a   Tilzey, John F ^a   Healy, William L ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Hemoglobin A1c; Infection; Total joint arthroplasty

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ABSCESS; ARTICLE; CELLULITIS; CORRELATIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; INFECTION RISK; POSTOPERATIVE INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

EID: 84859889948     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2011.09.013     Document Type: Article

References (15)

1. Golden S.H., Peart-Vigilance C., Kao W.H., et al. Preoperative glycemic control and risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999, 22:1408.
2. Krinsley J.S. Association between hyperglycemic and increased hospitalization in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings 2003, 78:1471.
3. Rizvi A.A., Chiloag S.A., Chiloag K.J. Peri-operative management of diabetes in hyperglycemia in patients undergoing orthopaedic surgery. J AAOS 2010, 18:426.
4. Fang A., Hu S.S., Enres N., et al. Risk factors for infection after spinal surgery. Spine 2005, 30:1460.
5. Marchant M.H., Viens N.A., Cook C., et al. The impact of glycemic control in diabetes mellitus on per-operative outcomes after total joint arthroplasty. J Bone Joint Surg, Am 2009, 91:1621.
6. Wimmar C., Gulch H., Franzrab M., et al. Predisposing factors for infection in spine surgery: a survey of 850 spinal procedures. J Spinal Disorders 1998, 11:124.
7. Miraovic D., Hipszer B.R., Epstein R.H., et al. Pre-admission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopaedic surgery. J Arthroplasty 2010, 25:64.
8. Parvizi J., Saleh K.J., Ragland P.S., et al. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop 2008, 79:335.
9. Lai K., Bohm E.R., Burnell C., et al. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty 2007, 22:651.
10. Jain N.B., Guller U., Pietrobon R., et al. Comorbidities increase complication rates in patients having arthroplasty. Clin Orthip Relat Res 2005, 232.
11. Yang K., Yeo S.J., Lee B.P., et al. Total knee Arthroplasty in diabetic patients: a study of 109 consecutive cases. J Arthroplasty 2001, 16:102.
12. Bourne R.B. Prophylactic use of antibiotic bone cement: an emerging standard-in the affirmative. J Arthroplasty 2004, 19(4 Suppl 1):69.
13. Chiu F.Y., Lin C.F. Antibiotic-impregnated cement in revision total knee arthroplasty. A prospective cohort study of one hundred and eighty-three knees. J Bone Joint Surg Am. 2009 Mar 1, 91:628.
14. Jamsen E., Huhtala H., Puolakka T., et al. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am 2009, 91:38.
15. Meding J.B., Reddleman K., Keating M.E., et al. Total knee replacement in patients with diabetes mellitus. Clin Orthop Relat Res 2003, 208.